EXPERIMENTAL STUDY
Mitochondrial ATP-sensitive K+ channels play a role in cardioprotection by Na+-H+ exchange inhibition against ischemia/reperfusion injury
Tetsuji Miura, MD, PhD*,
Yongge Liu, PhD ,
Mahiko Goto, MD, PhD*,
Akihito Tsuchida, MD, PhD*,
Takayuki Miki, MD, PhD*,
Atsushi Nakano, MD*,
Yasuhiro Nishino, MD*,
Yoshito Ohnuma, MD* and
Kazuaki Shimamoto, MD, PhD*
* Second Department of Internal Medicine, Sapporo Medical University School of Medicine, Sapporo, Japan
Maryland Research Laboratory, Otsuka America Pharmaceutical, Inc., Rockville, Maryland, USA
Manuscript received July 6, 2000;
revised manuscript received October 20, 2000,
accepted November 22, 2000.
Reprint requests and correspondence: Dr. Tetsuji Miura, Second Department of Internal Medicine, Sapporo Medical University School of Medicine, South-1 West-16, Chuo-ku, Sapporo 060-0061, Japan miura{at}sapmed.ac.jp
OBJECTIVES
The possible role of the ATP-sensitive potassium (KATP) channel in cardioprotection by Na+-H+ exchange (NHE) inhibition was examined.
BACKGROUND
The KATP channel is suggested to be involved not only in ischemic preconditioning but also in some pharmacological cardioprotection.
METHODS
Infarction was induced by 30-min coronary occlusion in rabbit hearts in situ or by 30-min global ischemia in isolated hearts. Myocardial stunning was induced by five episodes of 5-min ischemia/5-min reperfusion in situ. In these models, the effects of NHE inhibitors (cariporide and ethylisopropyl-amiloride [EIPA]) and the changes caused by KATP channel blockers were assessed. In another series of experiments, the effects of EIPA on mitochondrial KATP (mito-KATP) and sarcolemmal KATP (sarc-KATP) channels were examined in isolated cardiomyocytes.
RESULTS
Cariporide (0.6 mg/kg) reduced infarct size in situ by 40%, and this effect was abolished by glibenclamide (0.3 mg/kg), a nonselective KATP channel blocker. In vitro, 1 µM cariporide limited infarct size by 90%, and this effect was blocked by 5-hydroxydecanoate (5-HD), a mito-KATP channel blocker but not by HMR1098, a sarc-KATP channel blocker. Infarct size limitation by 1 µM EIPA was also prevented by 5-HD. Cariporide attenuated regional contractile dysfunction by stunning, and this protection was abolished by glibenclamide and 5-HD. Ethylisopropyl amiloride neither activated the mito-KATP channel nor enhanced activation of this channel by diazoxide, a KATP channel opener.
CONCLUSIONS
Opening of the mito-KATP channel contributes to cardioprotection by NHE inhibition, though the interaction between NHE and this KATP channel remains unclear.
|
Abbreviations and Acronyms
| | EIPA | = ethylisopropyl amiloride | | IK.ATP | = sarc-KATP channel current | | LV | = left ventricle or left ventricular | | LVDP | = left ventricular developed pressure | | LV dP/dt | = the first derivative of left ventricular pressure | | mito-KATP | = mitochondrial KATP channel | | NHE | = Na+-H+ exchanger | | sarc-KATP | = sarcolemmal KATP channel | | TTC | = triphenyltetrazolium chloride | | 5-HD | = 5-hydroxydecanoate |
|
This article has been cited by other articles:

|
 |

|
 |
 
C. D. Garciarena, C. I. Caldiz, M. V. Correa, G. R. Schinella, S. M. Mosca, G. E. Chiappe de Cingolani, H. E. Cingolani, and I. L. Ennis
Na+/H+ exchanger-1 inhibitors decrease myocardial superoxide production via direct mitochondrial action
J Appl Physiol,
December 1, 2008;
105(6):
1706 - 1713.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Javadov, A. Choi, V. Rajapurohitam, A. Zeidan, A. G. Basnakian, and M. Karmazyn
NHE-1 inhibition-induced cardioprotection against ischaemia/reperfusion is associated with attenuation of the mitochondrial permeability transition
Cardiovasc Res,
January 15, 2008;
77(2):
416 - 424.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Toda, T. Kadono, M. Hoshiai, Y. Eguchi, S. Nakazawa, H. Nakazawa, N. Higashijima, and H. Ishida
Na+/H+ exchanger inhibitor cariporide attenuates the mitochondrial Ca2+ overload and PTP opening
Am J Physiol Heart Circ Physiol,
December 1, 2007;
293(6):
H3517 - H3523.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. I. Caldiz, C. D. Garciarena, R. A. Dulce, L. P. Novaretto, A. M. Yeves, I. L. Ennis, H. E. Cingolani, G. Chiappe de Cingolani, and N. G. Perez
Mitochondrial reactive oxygen species activate the slow force response to stretch in feline myocardium
J. Physiol.,
November 1, 2007;
584(3):
895 - 905.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Schulze, C. Duschek, R. D. Lasley, and R. Bunger
Adenosine enhances cytosolic phosphorylation potential and ventricular contractility in stunned guinea pig heart: receptor-mediated and metabolic protection
J Appl Physiol,
March 1, 2007;
102(3):
1202 - 1213.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, C. Kinnear, J. M. Hammel, W. Zhu, Z. Hua, W. Mi, and C. A. Caldarone
Preservation of Mitochondrial Structure and Function After Cardioplegic Arrest in the Neonate Using a Selective Mitochondrial K(ATP) Channel Opener.
Ann. Thorac. Surg.,
May 1, 2006;
81(5):
1817 - 1823.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. D.T. Costa, K. D. Garlid, I. C. West, T. M. Lincoln, J. M. Downey, M. V. Cohen, and S. D. Critz
Protein Kinase G Transmits the Cardioprotective Signal From Cytosol to Mitochondria
Circ. Res.,
August 19, 2005;
97(4):
329 - 336.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Fujii, M. Avkiran, and D. J Chambers
Experimental studies on myocardial protection with intermittent cross-clamp fibrillation: additive effect of the sodium-hydrogen exchanger inhibitor, cariporide
Ann. Thorac. Surg.,
April 1, 2004;
77(4):
1398 - 1407.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Stevens, M. Salik Jahania, R. M. Mentzer Jr, and R. D. Lasley
Sodium-hydrogen exchange inhibition attenuates in vivo porcine myocardial stunning
Ann. Thorac. Surg.,
February 1, 2004;
77(2):
651 - 657.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Teshima, M. Akao, S. P. Jones, and E. Marban
Cariporide (HOE642), a Selective Na+-H+ Exchange Inhibitor, Inhibits the Mitochondrial Death Pathway
Circulation,
November 4, 2003;
108(18):
2275 - 2281.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Headrick, B. Hack, and K. J. Ashton
Acute adenosinergic cardioprotection in ischemic-reperfused hearts
Am J Physiol Heart Circ Physiol,
November 1, 2003;
285(5):
H1797 - H1818.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Ruiz-Meana, D. Garcia-Dorado, P. Pina, J. Inserte, L. Agullo, and J. Soler-Soler
Cariporide preserves mitochondrial proton gradient and delays ATP depletion in cardiomyocytes during ischemic conditions
Am J Physiol Heart Circ Physiol,
August 7, 2003;
285(3):
H999 - H1006.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. V. Haist, C. N. Hirst, and M. Karmazyn
Effective protection by NHE-1 inhibition in ischemic and reperfused heart under preconditioning blockade
Am J Physiol Heart Circ Physiol,
March 1, 2003;
284(3):
H798 - H803.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. C. Smith Jr, D. Faxon, W. Cascio, H. Schaff, T. Gardner, A. Jacobs, S. Nissen, and R. Stouffer
Prevention Conference VI: Diabetes and Cardiovascular Disease: Writing Group VI: Revascularization in Diabetic Patients
Circulation,
May 7, 2002;
105
(18):
e165 - e169.
[Full Text]
[PDF]
|
 |
|
|